IQVIA Pharma Deals Review
ISSN 1756-7874. The business journal providing incisive analysis and expert opinion on the major deals.
Pharma Deals Review Latest Articles
-
Merck & Co. Hands Over US$1.85 B to Acquire Pandion Therapeutics
-
Lilly Partners with Rigel on RIPK1 Inhibitors
-
Merck Ventures Further into Natural Killer Therapies with US$1.9 B Artiva Alliance
-
Coherus Catapults into Immuno-oncology Field with US$1.8 B Junshi Alliance
-
Novartis Licenses Anti-PD1 Antibody Tislelizumab from BeiGene in US$2.2 B Deal
You can click on any of the bars to open a new page with the corresponding deals.